Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients
Victoria Prockl, Florian T. Nickel, Kathrin S. Utz, Kilian Fröhlich, Tobias Engelhorn, Max J. Hilz, De-Hyung Lee, Ralf A. Linker, Konstantin Huhn
Topics & Concepts
OcrelizumabMedicineTolerabilityMultiple sclerosisAdverse effectSingle CenterInternal medicineRituximabImmunologyLymphomaMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersPolyomavirus and related diseases